follow us:

LinkedIn_Icon twitter-logo facebook-logo youtube-logo
HomeSitemapLegal NoticePrivacyContactPrint



Prof. Christoph Herwig
Vienna University of Technology, Austria





Working Party on Quality by Design



Biochemical processes producing value-added-products are and will remain critical to Europe’s competitiveness and, more importantly, essential to addressing important societal challenges, such as health and food. However, bioprocess development is often excessively long with a very high failure rate. Furthermore bioprocesses of industrial biotechnology producing chemical building blocks as well as technologies for the production of biosimilars also i) receive increased attention of the regulatory framework and ii) urge for more effectiveness in the process and product lifecycle, aiming at reducing cost of goods and optimizing productivity. In order to accelerate process development, to ensure scalability as well as transferability of processes between sites or process platforms, process understanding and knowledge gathered from other products, sites and processes must be readily utilised.

Concept of Quality by Design (QbD) has been introduced over 10 years ago in the (bio)pharmaceutical industries. QbD allows manufacturers to introduce process improvements without regulatory oversight, subject to proof process understanding. However, the full benefits of QbD are not exploited for many reasons: Most of the reasons fundamentally include gathering and transferring knowledge.



                                    Reference: GMP Navigator



MISSION of the Working Party on Quality by Design


What is Quality by Design... ?


Major objectives of the EFCE Working Party on Quality by Design


What do we aim to deliver?


Who is a member/ delegate of the Working Party?





© DECHEMA e.V. last update June 21, 2018